Dendritic cells and the control of immunity, Nature, vol.392, pp.245-52, 1998. ,
Cutting edge: self-antigen controls the balance between effector and regulatory T cells in peripheral tissues, J Immunol, vol.192, pp.1351-1356, 2014. ,
A functional variant in MicroRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus, PLoS Genet, vol.7, p.1002128, 2011. ,
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement, Immunity, vol.6, pp.411-418, 1997. ,
PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE, Eur J Immunol, vol.38, pp.2706-2723, 2008. ,
Recent insights into the role of the PD-1/ PD-L1 pathway in immunological tolerance and autoimmunity, Autoimmun Rev, vol.12, pp.1091-100, 2013. ,
Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus, Scand J Rheumatol, vol.38, pp.362-370, 2009. ,
Mortality in systemic lupus erythematosus, Arthritis Rheum, vol.54, pp.2550-2557, 2006. ,
Disease activity in systemic lupus erythematosus is associated with an altered expression of lowaffinity Fc? receptors and costimulatory molecules on dendritic cells, Immunology, vol.128, pp.334-375, 2009. ,
T cells as therapeutic targets in SLE, Nat Rev Rheumatol, vol.6, pp.317-342, 2010. ,
Clearance deficiency and systemic lupus erythematosus (SLE), J Autoimmun, vol.28, pp.114-135, 2007. ,
Clinical development of anti-RANKL therapy, Arthritis Res Ther, vol.9, p.7, 2007. ,
Current treatment of lupus nephritis, Lupus, vol.17, pp.426-456, 2008. ,
Belimumab for systemic lupus erythematosus, N Engl J Med, vol.368, pp.1528-1563, 2013. ,
Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis, Cardiovasc Res, vol.101, pp.203-213, 2014. ,
Selective delivery of ? cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice, Proc Natl Acad Sci, vol.105, pp.6374-6383, 2008. ,
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?, Autoimmun Rev, vol.13, pp.138-50, 2014. ,
Retroviral and lentiviral vectors for the induction of immunological tolerance, Scientifica, p.14, 2012. ,
Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?, Trends Immunol, vol.23, pp.296-300, 2002. ,
Toll-like receptors, tissue injury, and tumourigenesis, Mediators Inflamm, 2010. ,
Intracellular Toll-like receptors, Immunity, vol.32, pp.305-320, 2010. ,
Virulence mechanisms displayed by Salmonella to impair dendritic cell function, Curr Med Chem, vol.17, pp.1156-66, 2010. ,
The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis, Curr Pharm Des, vol.12, pp.131-178, 2006. ,
Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigen-presenting cell, Curr Pharm Des, vol.9, pp.233-277, 2003. ,
Genetic and pharmacological modulation of dendritic cell-T cell interactions as a therapeutic strategy for systemic lupus erythematosus, Curr Gene Ther, vol.11, 2011. ,
Determination of T-cell fate by dendritic cells, Immunol Cell Biol, vol.86, pp.389-97, 2008. ,
The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release, Immunity, vol.39, pp.521-557, 2013. ,
Engagement of NOD2 has a dual effect on proIL-1? mRNA transcription and secretion of bioactive IL-1?, Eur J Immunol, vol.38, pp.184-91, 2008. ,
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways, Clin Exp Immunol, vol.155, pp.487-95, 2009. ,
DAMPening inflammation by modulating TLR signalling, Mediators Inflamm, 2010. ,
Autoantibody induction by DNAcontaining immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway, J Immunol, vol.190, pp.5411-5433, 2013. ,
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors, Nature, vol.416, pp.603-610, 2002. ,
Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis, Circulation, vol.125, pp.1673-83, 2012. ,
The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis, J Biol Chem, vol.279, pp.17951-17957, 2004. ,
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide, Nature, vol.449, pp.564-573, 2007. ,
Self-RNAantimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8, J Exp Med, vol.206, pp.1983-94, 2009. ,
Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis, Exp Dermatol, vol.21, pp.327-357, 2012. ,
Antimicrobial peptides and self-DNA in autoimmune skin inflammation, Curr Opin Immunol, vol.20, pp.401-408, 2008. ,
Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells, J Immunol, vol.170, pp.24-31, 2003. ,
Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains, Eur J Immunol, vol.35, pp.3364-75, 2005. ,
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression, Arthritis Rheum, vol.52, pp.225-263, 2005. ,
Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus, Arthritis Res Ther, vol.14, p.155, 2012. ,
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review, Ann Rheum Dis, vol.69, pp.20-28, 2010. ,
Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9, J Clin Invest, vol.115, pp.407-424, 2005. ,
Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis, Science, vol.279, pp.1052-1056, 1998. ,
Fc receptor genes and the systemic lupus erythematosus diathesis, Autoimmunity, vol.40, pp.567-81, 2007. ,
Fc-receptors as regulators of immunity, Adv Immunol, vol.96, pp.179-204, 2007. ,
FcgammaRIV: a novel FcR with distinct IgG subclass specificity, Immunity, vol.23, pp.41-51, 2005. ,
FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications, Nat Rev Immunol, vol.10, pp.328-371, 2010. ,
Activating and inhibitory Fcgamma receptors can differentially modulate T cellmediated autoimmunity, Eur J Immunol, vol.38, pp.2241-50, 2008. ,
IgG Fc receptors, Annu Rev Immunol, vol.19, pp.275-90, 2001. ,
Immune complexinduced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells, Proc Natl Acad Sci U S A, vol.104, pp.13402-13409, 2007. ,
Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells, J Exp Med, vol.195, pp.1653-1662, 2002. ,
Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis, J Exp Med, vol.189, pp.187-94, 1999. ,
Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis, Immunity, vol.13, pp.277-85, 2000. ,
Disease activity in systemic lupus erythematosus is associated with an altered expression of lowaffinity Fc gamma receptors and costimulatory molecules on dendritic cells, Immunology, vol.128, pp.334-375, 2009. ,
Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG, J Immunol, vol.171, pp.3296-302, 2003. ,
Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen-and Sjogren's syndrome autoantigenassociated RNA, Arthritis Rheum, vol.54, pp.1917-1944, 2006. ,
C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes, Arthritis Rheum, vol.65, pp.1891-901, 2013. ,
Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells, J Immunol, vol.173, pp.4058-65, 2004. ,
Immune complexinduced enhancement of bacterial antigen presentation requires Fc? receptor III expression on dendritic cells, Proc Natl Acad Sci, vol.104, pp.13402-13409, 2007. ,
Distinct cell-specific control of autoimmunity and infection by Fc?RIIb, J Exp Med, vol.205, pp.883-95, 2008. ,
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses, J Exp Med, vol.178, pp.633-675, 1993. ,
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells, Nature, vol.372, pp.691-695, 1994. ,
A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection, J Clin Invest, vol.121, pp.2493-503, 2011. ,
Modulation of T cell function by TCR/pMHC binding kinetics, Immunobiology, vol.211, pp.47-64, 2006. ,
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation, J Exp Med, vol.173, pp.721-751, 1991. ,
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells, Front Immunol, issue.4, 2013. ,
CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance, Autoimmun Rev, vol.12, pp.1171-1177, 2013. ,
Reversal of the TCR stop signal by CTLA-4, Science, vol.313, pp.1972-1977, 2006. ,
Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis, Science, vol.273, pp.1864-1871, 1996. ,
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis, Proc Natl Acad Sci, vol.93, pp.2499-504, 1996. ,
Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance, J Immunol, vol.175, pp.124-154, 2005. ,
Phenotype and function of dendritic cells of patients with systemic lupus erythematosus, Clin Immunol, vol.143, pp.45-50, 2012. ,
Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?, J Allergy Clin Immunol, vol.113, pp.683-692, 2004. ,
TSLPactivated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med, vol.202, pp.1213-1236, 2005. ,
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice, J Exp Med, vol.208, pp.1579-84, 2011. ,
T-cell costimulation through B7RP-1 and ICOS, Nature, vol.402, pp.827-859, 1999. ,
Inducible costimulator protein (Icos) controls T helper cell subset polarization after virus and parasite infection, J Exp Med, vol.192, pp.53-62, 2000. ,
ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells, Eur J Immunol, vol.32, pp.2680-2686, 2002. ,
IL-2 therapy promotes suppressive ICOS + Treg expansion in melanoma patients, J Clin Invest, vol.124, pp.99-110, 2014. ,
Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection, Mol Med, vol.19, pp.346-56, 2013. ,
Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses, Nat Immunol, vol.4, pp.765-72, 2003. ,
Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammation, Autoimmun Rev, vol.13, pp.117-141, 2014. ,
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells, Blood, vol.95, pp.3489-97, 2000. ,
Intra-articular Fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis, PLoS One, vol.3, p.3633, 2008. ,
Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA, Rheumatology, vol.51, pp.932-972, 2012. ,
Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor + regulatory T cells, Immunity, vol.37, pp.264-75, 2012. ,
Expression of programmed death 1 ligands by murine T cells and APC, J Immunol, vol.169, pp.5538-5583, 2002. ,
PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding, Eur J Immunol, vol.37, pp.2405-2415, 2007. ,
PD-1 and its ligands in T-cell immunity, Curr Opin Immunol, vol.19, pp.309-323, 2007. ,
CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells, PLoS One, vol.28, p.83139, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02165637
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells, J Exp Med, vol.206, pp.3015-3044, 2009. ,
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells, Proc Natl Acad Sci U S A, vol.101, pp.10691-10697, 2004. ,
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor, Immunity, vol.11, pp.141-51, 1999. ,
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1, Nat Immunol, vol.13, pp.832-874, 2012. ,
Immunoregulation of dendritic cells by the receptor T cell Ig and mucin protein-3 via Bruton's tyrosine kinase and c-Src, J Immunol, vol.193, pp.3417-3442, 2014. ,
B lymphocytes enhance interferon-? production by plasmacytoid dendritic cells, Arthritis Rheum, vol.64, pp.3409-3428, 2012. ,
Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response, J Immunol, vol.177, pp.4196-202, 2006. ,
The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis, Ann N Y Acad Sci, vol.1051, pp.421-453, 2005. ,
Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus, Rheumatology (Oxford), vol.45, pp.1087-95, 2006. ,
Pathogen sensors and chemokine receptors in dendritic cell subsets, Vaccine, vol.30, pp.7652-7659, 2012. ,
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, Eur J Immunol, vol.31, pp.3388-93, 2001. ,
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12, Eur J Immunol, vol.31, pp.3026-3063, 2001. ,
Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation, J Immunol, vol.184, pp.1159-67, 2010. ,
Antigen-presentation properties of plasmacytoid dendritic cells, Immunity, vol.29, pp.352-61, 2008. ,
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation, J Exp Med, vol.197, pp.101-110, 2003. ,
Mouse and human dendritic cell subtypes, Nat Rev Immunol, vol.2, pp.151-61, 2002. ,
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors, Annu Rev Immunol, vol.23, pp.275-306, 2005. ,
Induction of antigenspecific human CD4+ T cell anergy by peripheral blood DC2 precursors, Eur J Immunol, vol.31, pp.2547-57, 2001. ,
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocytederived dendritic cells, J Leukoc Biol, vol.74, pp.1125-1163, 2003. ,
Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells, Blood, vol.107, pp.2423-2454, 2006. ,
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6, Immunity, vol.19, pp.225-259, 2003. ,
Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching, Immunol Cell Biol, vol.83, pp.554-62, 2005. ,
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help, Blood, vol.103, pp.3058-64, 2004. ,
Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment, Acta Oncol, vol.30, pp.537-577, 1991. ,
Autoimmune disease complicating antiviral therapy for hepatitis C virus infection, Semin Arthritis Rheum, vol.32, pp.163-73, 2002. ,
Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon, QJM, vol.91, pp.393-402, 1998. ,
Role of CD8alpha+ and CD8alpha-dendritic cells in the induction of primary immune responses in vivo, J Leukoc Biol, vol.66, pp.242-248, 1999. ,
Tolerogenic function of Blimp-1 in dendritic cells, J Exp Med, vol.208, pp.2193-2202, 2011. ,
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus, Nat Genet, vol.41, pp.1234-1241, 2009. ,
IFN-? regulates Blimp-1 expression via miR-23a and miR-125b in both monocytes-derived DC and pDC, PLoS One, vol.8, p.72833, 2013. ,
The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis, Lupus, vol.21, pp.1385-96, 2012. ,
Gene expression of cytokines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus, Lupus, vol.21, pp.1105-1117, 2012. ,
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity, Clin Immunol, vol.127, pp.385-93, 2008. ,
Suppressive effect of tobacco smoke extracts on oral P-glycoprotein function and its impact in smoke-induced insult to oral epidermal cells, Toxicol Lett, vol.185, pp.116-139, 2009. ,
CpG oligonucleotides induce the differentiation of CD4+ Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy, Immunol Lett, vol.142, pp.55-63, 2012. ,
Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells, J Immunol, vol.180, pp.5862-70, 2008. ,
TGF-?-exposed plasmacytoid dendritic cells participate in Th17 commitment, J Immunol, vol.186, pp.6157-64, 2011. ,
T-Independent immune response: new aspects of B cell biology, Science, vol.290, pp.89-92, 2000. ,
B-cell depletion in the treatment of lupus nephritis, Nat Rev Nephrol, vol.8, pp.505-519, 2012. ,
Antigen-specific interaction between T and B cells, Nature, vol.314, pp.537-546, 1985. ,
The who, how and where of antigen presentation to B cells, Nat Rev Immunol, vol.9, pp.15-27, 2009. ,
Lipopolysaccharideactivated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J Immunol, vol.167, pp.1081-1090, 2001. ,
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, vol.32, pp.129-169, 2010. ,
Interleukin-5 supports the expansion of Fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4 ,
, + T cells and secrete interleukin-10, PLoS One, vol.8, p.70131, 2013.
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2, J Exp Med, vol.185, pp.1909-1927, 1997. ,
Direct B cell stimulation by dendritic cells in a mouse model of lupus, Arthritis Rheum, vol.58, pp.1741-50, 2008. ,
Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70, Blood, vol.115, pp.3051-3058, 2010. ,
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL, Nat Immunol, vol.3, pp.822-831, 2002. ,
Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice, J Immunol, vol.192, pp.875-85, 2014. ,
Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage, Immunity, vol.33, pp.967-78, 2010. ,
Regulatory dendritic cells program B cells to differentiate into CD19hiFcgammaIIbhi regulatory B cells through IFN-beta and CD40L, Blood, vol.120, pp.581-91, 2012. ,
Regulatory T cells and immune tolerance, Cell, vol.133, pp.775-87, 2008. ,
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease, Immunol Rev, vol.212, pp.8-27, 2006. ,
Toll pathway-dependent blockade of CD4+CD25+ T cellmediated suppression by dendritic cells, Science, vol.299, pp.1033-1039, 2003. ,
IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions, J Immunol, vol.178, pp.271-280, 2007. ,
Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8 + T-cell effector differentiation by IL-2 modulation, PLoS One, vol.9, p.85455, 2014. ,
Cytokine production, serum levels and disease activity in systemic lupus erythematosus, Clin Exp Rheumatol, vol.18, pp.565-70, 2000. ,
Cytokines and systemic lupus erythematosus, Ann Rheum Dis, vol.59, pp.243-51, 2000. ,
Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, proinflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines, Clin Exp Rheumatol, vol.20, pp.535-543, 2002. ,
Rationale for interleukin-6 blockade in systemic lupus erythematosus, Lupus, vol.13, pp.339-382, 2004. ,
Tolerogenic dendritic cells, Annu Rev Immunol, vol.21, pp.685-711, 2003. ,
Dendritic cells in tolerance and autoimmune diabetes, Curr Opin Immunol, vol.25, pp.670-675, 2013. ,
Regulatory dendritic cell therapy: From rodents to clinical application, Immunol Lett, vol.161, pp.216-237, 2014. ,
Tolerogenic dendritic cells as a therapy for treating lupus, Clin Immunol, vol.148, pp.237-282, 2013. ,
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10, Blood, vol.95, pp.3162-3169, 2000. ,
Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways, Biochem Biophys Res Commun, vol.297, pp.645-52, 2002. ,
Glucocorticoids down-regulate dendritic cell function in vitro and in vivo, Eur J Immunol, vol.25, pp.2818-2842, 1995. ,
Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse, J Pharmacol Exp Ther, vol.312, pp.366-72, 2005. ,
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells, J Immunol, vol.166, pp.7053-62, 2001. ,
Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells, Blood, vol.100, pp.1084-1091, 2002. ,
Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo, Blood, vol.101, pp.4457-63, 2003. ,
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1, Eur J Immunol, vol.39, pp.3147-59, 2009. ,
Update on glucocorticoid action and resistance, J Allergy Clin Immunol, vol.111, pp.3-22, 2003. ,
Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A, Transpl Immunol, vol.20, pp.99-105, 2008. ,
Carbon monoxidetreated dendritic cells decrease ?1-integrin induction on CD8+ T cells and protect from type 1 diabetes, Eur J Immunol, vol.43, pp.209-227, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02164776
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression, Blood, vol.106, pp.1694-702, 2005. ,
Antigenspecific suppression of established arthritis in mice by dendritic cells deficient in NF-?B, Arthritis Rheum, vol.56, pp.2255-66, 2007. ,
Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses, J Immunol, vol.170, pp.1383-91, 2003. ,
Extracellular signalregulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in il-10-mediated selective repression of TNF-?-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells, J Immunol, vol.162, pp.3865-72, 1999. ,
Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLRmediated activation of antigen-presenting cells, Leukemia, vol.23, pp.535-579, 2008. ,
Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response, Curr Opin Pharmacol, vol.6, pp.379-86, 2006. ,
Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2-and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1, Eur J Immunol, vol.33, pp.1988-97, 2003. ,
CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity, Blood, vol.99, pp.2468-76, 2002. ,
Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells, Am J Respir Cell Mol Biol, vol.42, pp.190-199, 2010. ,
A gene signature of inhibitory MHC receptors identifies a BDCA3+ subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro, Eur J Immunol, vol.34, pp.2800-2811, 2004. ,
A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGFbeta+ tolerogenic dendritic cells, Immunobiology, vol.216, pp.1117-1143, 2011. ,
Protection of islet grafts through transforming growth factor-?-induced tolerogenic dendritic cells, Diabetes, vol.62, pp.3132-3174, 2013. ,
Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation, J Leukoc Biol, vol.84, pp.661-669, 2008. ,
Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collageninduced arthritis through Foxp3+ regulatory T cells, PLoS One, vol.7, p.40356, 2012. ,
Fasciola hepatica tegumental coat impairs mast cells' ability to drive Th1 immune responses, J Immunol, vol.190, pp.2873-2882, 2013. ,
RNAi therapeutics in autoimmune disease, Pharmaceuticals, vol.6, pp.287-94, 2013. ,
siRNA-based therapeutic approaches for rheumatic diseases, Nat Rev Rheumatol, vol.9, pp.56-62, 2013. ,
Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis, J Transl Med, vol.10, p.19, 2012. ,
Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells, J Immunol, vol.184, pp.6457-64, 2010. ,
RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis, Arthritis Res Ther, vol.12, p.13, 2010. ,
Tolerogenic dendritic cells produced by Lentiviral-mediated CD40-and IL-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing Th17 cells, Clin Exp Immunol, vol.176, pp.180-189, 2014. ,
Macrophages expressing heme oxygenase-1 improve renal function in ischemia/reperfusion injury, Mol Ther, vol.18, pp.1706-1719, 2010. ,
Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?, Autoimmun Rev, vol.12, pp.195-203, 2012. ,
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis, Mult Scler, vol.11, pp.367-71, 2005. ,
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR, J Rheumatol, vol.31, pp.482-490, 2004. ,
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus, JAMA, vol.295, pp.527-562, 2006. ,
C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus, JAMA, vol.301, pp.1573-1582, 2009. ,
Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease, J Immunol, vol.181, pp.7571-80, 2008. ,
Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes, J Clin Invest, vol.111, pp.1357-63, 2003. ,
The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus, Arthritis Res Ther, vol.8, p.118, 2006. ,
Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus, Immunology, vol.128, pp.306-320, 2009. ,
Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells, J Immunol, vol.178, pp.7849-58, 2007. ,
The histone peptide H471-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms, J Clin Immunol, vol.31, pp.379-94, 2011. ,
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models, Immunology, vol.128, pp.395-405, 2009. ,
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-? in murine and human systemic lupus erythematosus, PLoS One, vol.8, p.60394, 2013. ,
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis, N Engl J Med, vol.353, pp.2219-2247, 2005. ,
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev, vol.2, p.8794, 2011. ,
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials, JAMA, vol.295, pp.2275-85, 2006. ,
Cancer risk in immune-mediated inflammatory diseases (IMID), Mol Cancer, vol.12, p.98, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00859833
Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients, Diabetes Care, vol.34, pp.2026-2058, 2011. ,
Interview: immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic, Immunotherapy, vol.5, pp.919-940, 2013. ,
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients, Eur J Immunol, vol.42, pp.771-82, 2012. ,
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis, Ann Neurol, vol.73, pp.626-662, 2013. ,
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis, Eur J Immunol, vol.42, pp.569-72, 2012. ,
Feasibility, safety and clinical effects of Single intradermal administration of autologous tolerising dendritic cells exposed to citrullinated peptides in patients with rheumatoid arthritis, Arthritis Rheum, vol.63, p.2430, 2011. ,
Autoantigenesis: the evolution of protein modifications in autoimmune disease, Curr Opin Immunol, vol.24, pp.112-120, 2012. ,
Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?, Arthritis Rheum, vol.48, pp.300-312, 2003. ,
Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus, Scand J Immunol, vol.64, pp.668-76, 2006. ,
Induction of tolerogenic dendritic cells by NFkappaB blockade and Fcgamma receptor modulation, Methods Mol Biol, vol.677, pp.339-53, 2010. ,